Novo Nordisk programs Novo Nordisk operates multiple cost-reduction pathways through its NovoCare platform
The AWARD-11 trial results are currently being reviewed by the European Medicines Agency (EMA), and Lilly expects a recommendation decision on expanded doses in the EU by the end of 2020
Not every dizzy spell is a routine side effect
FDA has also approved dapagliflozin for treatment for CKD (2021) [26] and has given priority review for empagliflozin to potentially treat heart failure not associated with left ventricular ejection fraction [27]
Phase 2 trials will begin later this year
Other information Content details Last updated on 03 Aug 2026 | 01:02 AM (IST) Manufacturer details Name: A)Tata Consumer Products Limited Address: A)1, Bishop Lefroy road,Kolkata ,West Bengal 700 020/Brahman pally Village, Toopran Mandal, Tupran, Medak, Telangana-502334 Marketer details Name: TATA 1mg Healthcare Solutions Pvt